Sign In
Buy IPA
$1.62
+0 (+0%)
At Close: Jan 16, 2026
ImmunoPrecise Releases New Findings Showing LENSai™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the Clinic
08:22am, Thursday, 24'th Jul 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a Bio-Native AI pioneer operating where TechBio meets true biological intelli
ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board
08:28am, Monday, 21'st Jul 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-gen
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025
08:05am, Wednesday, 16'th Jul 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-gen
ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement
08:01am, Monday, 14'th Jul 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a company operating at the convergence of TechBio and biological intelligence
ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors
09:00am, Monday, 07'th Jul 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), an AI-powered biotherapeutics company, today announced the appointment of Jon
ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data
08:19am, Thursday, 03'rd Jul 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), an AI-powered biotherapeutics company, today announced a new validation study
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise (NASDAQ: IPA), a leader in AI-driven biotherapeutics, provides a significant update following its June 5, 2025, press release ImmunoPrecise A
AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies
08:01am, Thursday, 12'th Jun 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a leader in AI-powered drug discovery and biotherapeutics, today announced compelling in vitro results demonst
ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery
08:01am, Thursday, 05'th Jun 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $AMD #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics, announces discovery of a highly conserved epitope across all four d
ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts
08:49am, Wednesday, 21'st May 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) a leader in AI-driven biotherapeutics, today announced it has engaged CORE IR, a strategic investor and p
ImmunoPrecise Antibodies (IPA) to Present at Maxim Group's 2025 Virtual Tech Conference
08:28am, Tuesday, 20'th May 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) a leader in AI-driven biotherapeutics, today announced that Dr. Jennifer Bath, CEO of ImmunoPrecise Antib
IPA's LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed
08:01am, Monday, 12'th May 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $AMD #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics, is pleased to announce today new benchmarking results that validate
Fujifilm Invites Entries for its Innovation Print Awards Contest
10:00am, Monday, 05'th May 2025
HANOVER PARK, Ill.--(BUSINESS WIRE)--FUJIFILM North America Corporation, Business Innovation Division, has announced a call for entries to Fujifilm's global Innovation Print Awards (IPA) contest. The
10 Barrel Brewing Launches Non-Alcoholic Apocalypse IPA, a Bold Craft Brew for Your Next Adventure
07:00am, Wednesday, 30'th Apr 2025
BEND, Ore., April 30, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing, a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) craft beer brand, is excited to announce the launch of NA Apocalypse IPA, a non-al
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) a leader in AI-driven biotherapeutics, today announced its strong support for the U.S. Food and Drug Admi
